LiveRamp (RAMP) Competitors $31.98 -0.84 (-2.56%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$31.93 -0.05 (-0.17%) As of 08/1/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RAMP vs. HQY, MARA, ETSY, LYFT, WPP, AMTM, LIF, WSC, QBTS, and SEZLShould you be buying LiveRamp stock or one of its competitors? The main competitors of LiveRamp include HealthEquity (HQY), Marathon Digital (MARA), Etsy (ETSY), Lyft (LYFT), WPP (WPP), Amentum (AMTM), Life360 (LIF), WillScot (WSC), D-Wave Quantum (QBTS), and Sezzle (SEZL). These companies are all part of the "business services" industry. LiveRamp vs. Its Competitors HealthEquity Marathon Digital Etsy Lyft WPP Amentum Life360 WillScot D-Wave Quantum Sezzle HealthEquity (NASDAQ:HQY) and LiveRamp (NYSE:RAMP) are both mid-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation. Do insiders & institutionals believe in HQY or RAMP? 99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 93.8% of LiveRamp shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 3.3% of LiveRamp shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is HQY or RAMP more profitable? HealthEquity has a net margin of 9.80% compared to LiveRamp's net margin of -0.11%. HealthEquity's return on equity of 11.01% beat LiveRamp's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity9.80% 11.01% 6.77% LiveRamp -0.11%1.33%1.02% Which has more risk & volatility, HQY or RAMP? HealthEquity has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, LiveRamp has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Do analysts prefer HQY or RAMP? HealthEquity presently has a consensus target price of $118.55, indicating a potential upside of 30.18%. LiveRamp has a consensus target price of $41.29, indicating a potential upside of 29.10%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts plainly believe HealthEquity is more favorable than LiveRamp.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00LiveRamp 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43 Which has stronger valuation & earnings, HQY or RAMP? HealthEquity has higher revenue and earnings than LiveRamp. LiveRamp is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$1.20B6.56$96.70M$1.3766.47LiveRamp$745.58M2.79-$810K-$0.01-3,198.00 Does the media refer more to HQY or RAMP? In the previous week, LiveRamp had 5 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for LiveRamp and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.70 beat LiveRamp's score of 0.68 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LiveRamp 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHealthEquity beats LiveRamp on 14 of the 17 factors compared between the two stocks. Get LiveRamp News Delivered to You Automatically Sign up to receive the latest news and ratings for RAMP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RAMP vs. The Competition Export to ExcelMetricLiveRampTechnology Services IndustryBusiness SectorNYSE ExchangeMarket Cap$2.13B$2.52B$14.77B$20.69BDividend YieldN/A1.59%2.80%3.67%P/E Ratio-3,198.0019.1124.0529.07Price / Sales2.7980.8168.2957.23Price / Cash89.3545.3226.9422.84Price / Book2.225.085.074.43Net Income-$810K$33.37M$195.86M$994.22M7 Day Performance-2.53%-4.62%-4.24%-3.35%1 Month Performance-3.12%0.59%-1.10%-2.05%1 Year Performance11.16%48.85%28.98%10.15% LiveRamp Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RAMPLiveRamp4.6548 of 5 stars$31.98-2.6%$41.29+29.1%+7.9%$2.13B$745.58M-3,198.001,300Positive NewsUpcoming EarningsHQYHealthEquity3.7212 of 5 stars$97.08-0.6%$118.55+22.1%+16.9%$8.39B$1.20B70.863,120Positive NewsGap DownMARAMarathon Digital4.0889 of 5 stars$18.83-3.5%$21.28+13.0%-14.6%$6.63B$656.38M-12.999Analyst ForecastAnalyst RevisionGap DownETSYEtsy3.5412 of 5 stars$60.41+1.3%$51.13-15.4%-2.3%$6.30B$2.81B43.152,400Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionLYFTLyft4.3465 of 5 stars$14.77+0.1%$16.82+13.9%+19.3%$6.17B$5.79B98.472,934Trending NewsUpcoming EarningsAnalyst ForecastWPPWPP3.0131 of 5 stars$27.98+0.5%N/A-42.7%$6.04B$18.84B4.69108,044Upcoming EarningsHigh Trading VolumeAMTMAmentum0.9828 of 5 stars$24.73-2.0%$25.22+2.0%N/A$6.02B$8.39B0.0053,000Upcoming EarningsLIFLife3601.7862 of 5 stars$74.61+0.3%$59.50-20.3%+122.2%$5.71B$396.88M829.00600Upcoming EarningsAnalyst ForecastGap DownWSCWillScot4.0252 of 5 stars$29.73-2.2%$40.63+36.6%-36.4%$5.42B$2.40B330.374,500Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastShort Interest ↑Gap DownQBTSD-Wave Quantum2.3182 of 5 stars$18.39-2.6%$14.38-21.8%+1,597.6%$5.37B$8.83M-30.653Trending NewsUpcoming EarningsAnalyst ForecastGap UpSEZLSezzle2.4603 of 5 stars$135.98-3.3%$108.28-20.4%+1,021.8%$4.53B$271.13M45.94540News CoveragePositive NewsUpcoming EarningsInsider TradeGap Down Related Companies and Tools Related Companies HQY Competitors MARA Competitors ETSY Competitors LYFT Competitors WPP Competitors AMTM Competitors LIF Competitors WSC Competitors QBTS Competitors SEZL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RAMP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LiveRamp Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LiveRamp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.